HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
Shiyu Wang,Guoxiong Xu,Fan Chao,Cong Zhang,Dunsheng Han,Gang Chen
DOI: https://doi.org/10.2147/CMAR.S330713
2021-09-21
Cancer Management and Research
Abstract:Shiyu Wang, 1, 2 Guoxiong Xu, 3 Fan Chao, 1, 2 Cong Zhang, 1, 2 Dunsheng Han, 1, 2 Gang Chen 1, 2 1 Department of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, People's Republic of China; 2 Department of Surgery, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China; 3 Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, 201508, People's Republic of China Correspondence: Gang Chen Department of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, People's Republic of China Tel +86-21-34189990-5516 Fax +86-21-67226966 Email Introduction: The incidence of prostate cancer remains high worldwide, while exploring new therapeutic targets for prostate cancer is essential. Heterogeneous nuclear ribonucleoproteins have been proved to regulate tumorigeneses in various cancers. This study aimed to explore the role of HNRNPC in prostate cancer progression. Methods: HNRNPC expression and its correlation with clinical features and immune infiltration were analyzed by bioinformatics analysis. The effects of HNRNPC on prostate cell proliferation, migration, and invasion were accessed by EdU, colony formation, transwell, and wound-healing assays. Results: The expression level of HNRNPC was significantly increased in prostate cancer tissues and was correlated with the T stage, N stage, Gleason score, PSA level, residual tumors, overall survival, disease-specific survival, and progression-free interval of prostate cancer patients. Silencing HNRNPC inhibited the proliferation and metastasis of prostate cancer cells. The expression of HNRNPC was negatively correlated with the infiltration level of most immune cells in prostate cancer. Mechanistically, HNRNPC may function through regulating gene expression at the posttranscriptional level. Conclusion: HNRNPC could be a potential marker for the treatment and prognosis prediction of prostate cancer. Keywords: HNRNPC, prostate cancer, proliferation, metastasis, immune infiltration The incidence and mortality of prostate cancer keep rising. Studying the factors that affect the occurrence and development of prostate cancer is of great significance for clinical diagnosis, treatment, and prognosis. In this study, we identified a new abnormal expression gene in prostate cancer-HNRNPC and found that its expression level was correlated with multiple clinicopathologic characteristics of prostate cancer, including T stage, N stage, PSA level, Gleason score, residual tumor, overall survival, disease-specific survival, and progression-free interval. We also found that HNENPC expression level was correlated with immune cells infiltration. Further, we proved that HNRNPC promoted the proliferation, migration, invasion of PCa cells in vitro and predicted its functional mechanism with the help of bioinformatics analysis. Our study may provide a promising target for the diagnostic and therapeutic application in patients with prostate cancer. Prostate cancer (PCa) is a dangerous disease in men. In 2021, the estimated cases of PCa are 248,530, accounting for 26% of male tumors and ranking the first in male tumor incidence; the estimated deaths are 34,130, ranking the second in male cancer mortality. 1 Usually, localized PCa can be treated with radical surgery and achieve a good result, but tumor recurrence and metastasis still occur from time to time. Advanced PCa is usually treated with androgen deprivation therapy (ADT). 2 However, after a period of ADT treatment, most patients will eventually turn into castration-resistant prostate cancer (CRPC), which has relatively been restricted in response to existing treatments. 3 Once a patient enters a castration-resistant state, he is more likely to die of his PCa than other causes. 2 Therefore, finding new targets for diagnosis, treatment, and prognostic prediction of PCa is necessary. RNA alternative splicing is essential for gene expression regulation and is responsible for various biological processes, such as cellular homeostasis, cellular function regulation, tissue development, and so on. 4,5 The dysfunction of alternative splicing contributes to many disorders, including cancer. 6,7 The heterogeneous nuclear ribonucleoprotein (HNRNP) family is the most critical alternative splicing regulator, which complexes with heterogeneous nuclear RNA (hnRNA) and plays essential roles in RNA maturation, stabilization, translocation, and posttranscriptional modification, etc. 8–10 HNRNPC is the first HNRNP family member found to regulate RNA splicing, 11</s -Abstract Truncated-
oncology